Overview
7-Ethylcamptothecin (7-EtCPT) is a synthetic analog of camptothecin, a natural alkaloid derived from the Camptotheca acuminata tree. It belongs to the class of topoisomerase I inhibitors, which are critical in disrupting DNA replication in cancer cells. The ethyl substitution at the 7-position enhances its stability and bioactivity compared to the parent compound. This compound has gained prominence in oncology research due to its mechanism of action, which involves stabilizing the DNA-topoisomerase I complex, leading to DNA damage and apoptosis in rapidly dividing cells. Its synthetic origin allows for consistent quality and scalable production, making it a preferred choice for pharmaceutical development.
Physical and Chemical Properties
7-Ethylcamptothecin appears as a pale yellow to yellow crystalline powder with a molecular weight of 376.41 g/mol. It is sparingly soluble in water but dissolves well in organic solvents like dimethyl sulfoxide (DMSO) and methanol, which facilitates its use in laboratory and clinical settings. The compound exhibits a melting point around 260-265°C, with decomposition occurring at higher temperatures. Its stability is influenced by environmental factors such as light and humidity, necessitating storage under controlled conditions. The ethyl group at the 7-position contributes to its enhanced lipophilicity, improving cellular uptake and bioavailability compared to unmodified camptothecin.
Main Applications
7-Ethylcamptothecin is primarily utilized in cancer research and therapy, particularly in studies targeting solid tumors and hematological malignancies. Its ability to inhibit topoisomerase I makes it a valuable tool for investigating DNA repair mechanisms and developing novel chemotherapeutic agents. In clinical settings, derivatives of 7-EtCPT are explored for their efficacy in combination therapies, often paired with other anticancer drugs to enhance treatment outcomes. Beyond oncology, it serves as a reference compound in biochemical assays to evaluate the activity of other topoisomerase inhibitors. Its applications extend to drug formulation studies, where its solubility and stability profiles are optimized for intravenous or oral delivery.
Safety and Storage
Due to its potent biological activity, 7-Ethylcamptothecin requires careful handling to minimize exposure. Personal protective equipment (PPE), including gloves and lab coats, is essential when working with this compound. Inhalation or skin contact should be avoided, as it may cause irritation or systemic effects. Storage recommendations include keeping the compound in a tightly sealed container at -20°C, protected from light and moisture to prevent degradation. Long-term stability can be ensured by aliquoting the powder into smaller quantities to reduce repeated freeze-thaw cycles. Disposal should comply with local regulations for hazardous chemicals, typically through incineration or specialized waste management services.
B2B Procurement Guide
When procuring 7-Ethylcamptothecin, buyers should prioritize suppliers with demonstrated expertise in fine chemicals and pharmaceutical intermediates. Key considerations include verifying the certificate of analysis (CoA), which should specify purity (≥98% by HPLC) and confirm the absence of toxic impurities. Bulk purchases often require negotiation for volume discounts, though prices may fluctuate based on market demand and synthesis complexity. Lead times can vary, so advance planning is advisable for research or production schedules. Reputable suppliers typically provide technical support, including solubility data and handling recommendations, to ensure safe and effective use. Import/export regulations may apply, particularly for international shipments, due to its classification as a bioactive compound.